Evidence map›Paper›PMID 10077569›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Transcriptional activation by artificial recruitment in mammalian cells.

J Nevado, L Gaudreau, M Adam, M Ptashne

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The transition from transcriptional initiation to elongation.Current opinion in genetics & development · 2008
    Review
  7. Review
  8. Article
  9. Antithetic effects of MBD2a on gene regulation.Molecular and cellular biology · 2003
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. An artificial transcriptional activating region with unusual properties.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J NevadoMolecular Biology Program, Sloan-Kettering Institute, New York, NY 10021, USA.
L Gaudreau
M Adam
M Ptashne
Kettering University · US

Funding

RATIONAL DEVELOPMENT OF NOVEL ANTIAIDS DRUGSR01AI031343 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEE-HUANG, SYLVIA · 1992 to 1998
–
RATIONAL DEVELOPMENT OF NOVEL ANTI-AIDS DRUGSR55AI031343 · NIAID · NEW YORK UNIVERSITY · PI LEE-HUANG, SYLVIA · 1991 to 1991
–
NIAID NIH HHS AI-31343
6 · The paper itself

Abstract

We show that the typical "nonclassical" activator, which comprises a fusion protein bearing a component of the transcriptional machinery fused to a DNA-binding domain, activates transcription in mammalian cells only weakly when tested with an array of promoters. However, as found in analogous "artificial recruitment" experiments performed in yeast, these activators work synergistically with "classical" activators. The effect of the classical activator in such experiments requires that it be tethered to DNA, a requirement that cannot be overcome by expression of that classical activator at high levels. The effect of the one nonclassical activator that does elicit significant levels of transcription when working alone (i.e., that bearing TATA box-binding protein) is strongly influenced by promoter architecture. The results, consistent with those of analogous experiments in yeast [see the accompanying paper: Gaudreau, L., Keaveney, M., Nevado, J., Zaman, Z., Bryant, G. O., Struhl, K. & Ptashne, M. (1999) Proc. Natl. Acad. Sci. USA 96, 2668-2673], suggest that classical activators, presumably by virtue of their abilities to interact with multiple targets, have a functional flexibility that nonclassical activators lack.

Indexed as

Transcriptional ActivationTranscription FactorsTranscription, GeneticHeLa CellsHumansTranscription Factors

Identifiers

PMID10077569
PMCPMC15827
OpenAlexW2037536891

What OpenQuestion holds

Texttitle and abstract
reference markers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.